147 related articles for article (PubMed ID: 30664347)
21. A computational insight into endocrine disruption by polychlorinated biphenyls via non-covalent interactions with human nuclear receptors.
Akinola LK; Uzairu A; Shallangwa GA; Abechi SE
Ecotoxicol Environ Saf; 2021 May; 214():112086. PubMed ID: 33640727
[TBL] [Abstract][Full Text] [Related]
22. Monohaloacetonitriles induce cytotoxicity and exhibit different mode of action in endocrine disruption.
Park CG; Jung KC; Kim DH; Kim YJ
Sci Total Environ; 2021 Mar; 761():143316. PubMed ID: 33190885
[TBL] [Abstract][Full Text] [Related]
23. Characterization of estrogenic and androgenic activity of phthalates by the XenoScreen YES/YAS in vitro assay.
Czernych R; Chraniuk M; Zagożdżon P; Wolska L
Environ Toxicol Pharmacol; 2017 Jul; 53():95-104. PubMed ID: 28528305
[TBL] [Abstract][Full Text] [Related]
24. Disruption of classical estrogenic targets in brown trout primary hepatocytes by the model androgens testosterone and dihydrotestosterone.
Lopes C; Madureira TV; Gonçalves JF; Rocha E
Aquat Toxicol; 2020 Oct; 227():105586. PubMed ID: 32882451
[TBL] [Abstract][Full Text] [Related]
25. Widely used pharmaceuticals present in the environment revealed as in vitro antagonists for human estrogen and androgen receptors.
Ezechiáš M; Janochová J; Filipová A; Křesinová Z; Cajthaml T
Chemosphere; 2016 Jun; 152():284-91. PubMed ID: 26978704
[TBL] [Abstract][Full Text] [Related]
26. ERα-agonist and ERβ-antagonist bifunctional next-generation bisphenols with no halogens: BPAP, BPB, and BPZ.
Liu X; Matsuyama Y; Shimohigashi M; Shimohigashi Y
Toxicol Lett; 2021 Jul; 345():24-33. PubMed ID: 33857583
[TBL] [Abstract][Full Text] [Related]
27. Effects of environmental estrogens and antiandrogens on endocrine function, gene regulation, and health in fish.
Rempel MA; Schlenk D
Int Rev Cell Mol Biol; 2008; 267():207-52. PubMed ID: 18544500
[TBL] [Abstract][Full Text] [Related]
28. Androgens and bone.
Vanderschueren D; Vandenput L; Boonen S; Lindberg MK; Bouillon R; Ohlsson C
Endocr Rev; 2004 Jun; 25(3):389-425. PubMed ID: 15180950
[TBL] [Abstract][Full Text] [Related]
29. On selecting a minimal set of in vitro assays to reliably determine estrogen agonist activity.
Judson RS; Houck KA; Watt ED; Thomas RS
Regul Toxicol Pharmacol; 2017 Dec; 91():39-49. PubMed ID: 28993267
[TBL] [Abstract][Full Text] [Related]
30. The mixture effects of bisphenol derivatives on estrogen receptor and androgen receptor.
Park C; Song H; Choi J; Sim S; Kojima H; Park J; Iida M; Lee Y
Environ Pollut; 2020 May; 260():114036. PubMed ID: 31995776
[TBL] [Abstract][Full Text] [Related]
31. Roles of estrogens, estrogen-like compounds, and endocrine disruptors in adipocytes.
Lizcano F
Front Endocrinol (Lausanne); 2022; 13():921504. PubMed ID: 36213285
[TBL] [Abstract][Full Text] [Related]
32. Comparing the androgenic and estrogenic properties of progestins used in contraception and hormone therapy.
Louw-du Toit R; Perkins MS; Hapgood JP; Africander D
Biochem Biophys Res Commun; 2017 Sep; 491(1):140-146. PubMed ID: 28711501
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of new alternative methods for the identification of estrogenic, androgenic and steroidogenic effects: a comparative in vitro/in silico study.
Najjar A; Wilm A; Meinhardt J; Mueller N; Boettcher M; Ebmeyer J; Schepky A; Lange D
Arch Toxicol; 2024 Jan; 98(1):251-266. PubMed ID: 37819454
[TBL] [Abstract][Full Text] [Related]
34. Comparison of hormonal activity (estrogen, androgen and progestin) of standardized plant extracts for large scale use in hormone replacement therapy.
Beck V; Unterrieder E; Krenn L; Kubelka W; Jungbauer A
J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):259-68. PubMed ID: 12711012
[TBL] [Abstract][Full Text] [Related]
35. The application of reporter gene assays for the detection of endocrine disruptors in sport supplements.
Plotan M; Elliott CT; Scippo ML; Muller M; Antignac JP; Malone E; Bovee TF; Mitchell S; Connolly L
Anal Chim Acta; 2011 Aug; 700(1-2):34-40. PubMed ID: 21742114
[TBL] [Abstract][Full Text] [Related]
36. In house validation of recombinant yeast estrogen and androgen receptor agonist and antagonist screening assays.
Kolle SN; Kamp HG; Huener HA; Knickel J; Verlohner A; Woitkowiak C; Landsiedel R; van Ravenzwaay B
Toxicol In Vitro; 2010 Oct; 24(7):2030-40. PubMed ID: 20732407
[TBL] [Abstract][Full Text] [Related]
37. Pesticides as estrogen disruptors: QSAR for selective ERα and ERβ binding of pesticides.
Agatonovic-Kustrin S; Alexander M; Morton DW; Turner JV
Comb Chem High Throughput Screen; 2011 Feb; 14(2):85-92. PubMed ID: 20958252
[TBL] [Abstract][Full Text] [Related]
38. Characterization of estrogen receptor α activities in polychlorinated biphenyls by in vitro dual-luciferase reporter gene assay.
Zhang Q; Lu M; Wang C; Du J; Zhou P; Zhao M
Environ Pollut; 2014 Jun; 189():169-75. PubMed ID: 24675366
[TBL] [Abstract][Full Text] [Related]
39. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays.
Sonneveld E; Jansen HJ; Riteco JA; Brouwer A; van der Burg B
Toxicol Sci; 2005 Jan; 83(1):136-48. PubMed ID: 15483189
[TBL] [Abstract][Full Text] [Related]
40. Rapid and reagent-free bioassay using autobioluminescent yeasts to detect agonistic and antagonistic activities of bisphenols against rat androgen receptor and progesterone receptor.
Huang Y; Zhang W; Zhang C; Cui N; Xiao Z; Wang R; Su X
J Steroid Biochem Mol Biol; 2022 Sep; 222():106151. PubMed ID: 35787454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
